Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03447743 · ClinicalTrials.gov registry record · Early Phase 1
Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder
A Early Phase 1 study, sponsored by Michele Staton.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT03447743: Completed Early Phase 1 study, sponsored by Michele Staton.
NCT03447743 is a Early Phase 1 study that has completed, run by Michele Staton. The registered enrollment target is 9 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03447743, a Early Phase 1 study, has completed, sponsored by Michele Staton.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
The overall aim of this R34 proposal is to examine the feasibility, acceptability, and short-term outcomes associated with an innovative service delivery model to increase adherence to extended-release naltrexone (XR-NTX) during the transition from jail to the community for rural individuals with opioid use disorder (OUD). The significance of this study is grounded in the public health emergency associated with the opioid epidemic in rural Appalachia, the increased vulnerability of rural individuals with OUD, and the dearth of available and accessible evidence-based treatment in the region. This study has potential to make a significant contribution to the OUD treatment field by advancing knowledge on innovative service delivery models to increase access to evidence-based treatment to reduce the prevalence of opioid use disorders and related health disparities among hard-to-reach, high-risk, underserved populations.
Primary Outcome
Study enrollment is defined as the number of participants who initiate XR-NTX.
Interventions
- DRUG XR-NTX community location
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-09-11 |
| Est. Completion | 2022-03-09 |
| Phase | Early Phase 1 |
What the finished NCT03447743 record still lists
NCT03447743 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which XR-NTX community location is the first listed.
NCT03447743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03447743 about?
NCT03447743 is a clinical study titled "Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder". The overall aim of this R34 proposal is to examine the feasibility, acceptability, and short-term outcomes associated with an innovative service delivery model to increase adherence to extended-release naltrexone (XR-NTX) during the transition from jail to the community for rural individuals with op...
What is the current status of trial NCT03447743?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2019-09-11. Estimated completion is 2022-03-09.
What interventions are being tested in trial NCT03447743?
The interventions under investigation include: XR-NTX community location (DRUG).
Who is sponsoring clinical trial NCT03447743?
This trial is sponsored by Michele Staton, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03447743's enrollment target sits among peer trials
9 1746th of 2000 higher than 219 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI